临床试验药物安全性 1506条(本栏目收费,不能显示细节,电话15274084725)
Bacillus anthracis infections,treating,20,21 21
Bacillus Calmette-Guerin (BCG),593 593
Binary variables,237,239,241,243 243
Biological license application (BLA),802,803,811,812 812
Biomarker validation from FDA submissions for in vitro diagnostics tests,413,417 417
distinctions between submission for medical devices,416,417 417
validation of genomic DNA diagnostic reagent in a 510(k) submission,413,414 414
validation PCR reaction diagnostic test in a 519(k) submission,414,415 415
in a PMA submission,415,416 416
Biomarkers breast cancer,382,390 390
circulating tumor cells,387,388,405,408 408
colorectal cancer,388,389 389
DNA microarray colon cancer,392,393 393
hepatocellular carcinoma,393 393
exploratory biomarkers,400 400
measurement relative to chemotherapy,374 374